MSDx msdx.co


Public lists: Medical Devices (6123)

MSDx is engaged in an effort to improve the diagnosis of Multiple Sclerosis by offering the first definitive, simple, fast, and cost effective blood test for health care professionals and patients around the world.

MSDx is engaged in an effort to improve the diagnosis of Multiple Sclerosis by offering the first definitive, simple, fast, and cost effective blood test for health care professionals and patients around the world.

Company (Alive / Active)

Phone: 888-647-6739

Fax:

245 S Plumer Ave
# 7
Tucson, 85719
Arizona, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
MSDx $1.5M Jun 2, 2014
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related MSDx Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Abaxis

Union City, California, United States
AcquiredAbaxis supplies point of care blood analyzers to the medical market and the veterinarian market. Abaxis provides technology, tools and services that support best medical practices, enabling physicians and veterinarians to respond to the health needs of their clients at the point of care while operating economical and profitable practices. Abaxis is headquartered in northern California, USA, and conducts operations around the world.Login to see details

Oxford Immunotec

Oxfordshire, United Kingdom
IPO / Went publicOxford Immunotec (NASDAQ:OXFD) is a global diagnostics company focused on developing and commercializing proprietary tests for the management of under-served immune-regulated conditions. T-SPOT is their platform technology, designed to simply and accurately examine a patient's cellular immune response to infection; the first product to come from this platform is the T-SPOT.TB Test, which is used to test for tuberculosis infection. The company's second product line is a range of assays for tick-b...Show allLogin to see details
See all 16 competitors